| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | CSE Bulletin: Name and Symbol Change - Red Light Holland Corp. (TRIP) | 82 | Newsfile | Le 30 juillet/July 2026
Red Light Holland Corp. (TRIP) has announced a name and symbol change to Rhelion Life Sciences Corp. (RELH).
Shares will begin trading under the new name and symbol and... ► Artikel lesen | |
| RED LIGHT HOLLAND Aktie jetzt für 0€ handeln | |||||
| Mi | Red Light Holland reports FY results | 4 | Seeking Alpha | ||
| Mi | Red Light Holland Corp.: Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences | 268 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing... ► Artikel lesen | |
| 17.07. | Red Light Holland Corp: Red Light to change name to Rhelion Life Sciences | 2 | Stockwatch | ||
| 17.07. | Red Light Holland to rebrand to Rhelion Life Sciences | 3 | Seeking Alpha | ||
| 17.07. | Red Light Holland Corp.: Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp | 400 | Newsfile | Rhelion Life Sciences reflects the Company's evolution into a sharpened focused, science-driven life sciences platform dedicated to psychedelic drug discovery, development, and innovationToronto... ► Artikel lesen | |
| 17.07. | Red Light Holland Corp: Red Light's Filament completes PEX010 shipment into EU | 6 | Stockwatch | ||
| 16.07. | Red Light Holland Corp.: Red Light Holland Announces New Filament Health PEX010 European Research Shipment | 440 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization... ► Artikel lesen | |
| 09.07. | Red Light Holland Corp: Red Light's Filament offers 0.5 mg dose of PEX010 | 4 | Stockwatch | ||
| 08.07. | Red Light Holland Corp.: Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosi | 287 | Newsfile | Filament Health has commenced the largest production run in its history of its standardized, patented PEX010 botanical psilocybin drug candidate, introducing a new 0.5 mg dose alongside its existing... ► Artikel lesen | |
| 08.07. | Red Light Holland Corp: Red Light Holland's Filament to supply PEX010 to ARQ | 7 | Stockwatch | ||
| 07.07. | Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre | 397 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization... ► Artikel lesen | |
| 18.06. | Red Light Holland reports coca leaf extract study results | 6 | Investing.com | ||
| 18.06. | Red Light Holland meldet Studienergebnisse zu Kokablatt-Extrakt mit Potenzial bei Gewichtskontrolle | 3 | Investing.com Deutsch | ||
| 18.06. | Red Light Holland Corp.: Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health | 346 | Newsfile | Whole leaf coca extract under evaluation is Magdalena's drug candidate for post GLP-1 weight loss managementToronto, Ontario--(Newsfile Corp. - June 18, 2026) - Red Light Holland Corp. (CSE: TRIP)... ► Artikel lesen | |
| 08.06. | Red Light Holland Corp: Red Light's Filament to supply PEX010 for French group | 9 | Stockwatch | ||
| 08.06. | Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France | 437 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization... ► Artikel lesen | |
| 04.06. | Red Light Holland Corp: Red Light Holland's psilocybin selected for UCSF study | 5 | Stockwatch | ||
| 04.06. | Red Light Holland Corp.: Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers | 538 | Newsfile | Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and stabilization methods to an independently sponsored UCSF... ► Artikel lesen | |
| 25.05. | Red Light Holland Corp: Red Light expands NZ psilocybin supply partnership | 4 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,050 | -0,81 % | Wirkstoffe, Zukäufe, Aufspaltungen: Werden Bayer, Novo Nordisk, BioNxt oder Evotec zu Top-Übernahme-Kandidaten? | Nach einer jahrelangen Konsolidierung fragen sich Investoren: Geht es auch mal wieder aufwärts? Der globale LifeScience-Sektor steht auch im Jahr 2026 vor einer massiven Konsolidierungswelle, da etablierte... ► Artikel lesen | |
| NOVO NORDISK | 40,900 | -7,36 % | Novo Nordisk revolutionierte Diabetes, CAR-T die Krebsmedizin - könnte Mesoblast die nächste Biotech-Plattform aufbauen? | ||
| NOVARTIS | 135,74 | +0,28 % | BERENBERG stuft NOVARTIS AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Novartis von 110 auf 120 Franken angehoben und die Einstufung auf "Hold" belassen. Mit der Anpassung trage sie den soliden... ► Artikel lesen | |
| AURORA CANNABIS | 2,422 | +0,25 % | Aurora Cannabis Inc (3): Aurora gets ISS backing ahead of annual meeting vote | ||
| SANOFI | 75,00 | -0,32 % | BERNSTEIN RESEARCH stuft SANOFI auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Sanofi auf "Outperform" mit einem Kursziel von 107 Euro belassen. Die neue Konzernchefi unternehme weitere... ► Artikel lesen | |
| GSK | 22,580 | -0,26 % | JEFFERIES stuft GSK auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für GSK nach Quartalszahlen auf "Buy" mit einem Kursziel von 2500 Pence belassen. Der Umsatz habe die Konsensschätzung etwas... ► Artikel lesen | |
| CANOPY GROWTH | 0,790 | -0,65 % | Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First. | ||
| ELI LILLY | 997,50 | +0,15 % | Novo Nordisk und Eli Lilly zeigen, wie Blockbuster entstehen - warum Biotech-Unternehmen mit Produkten plötzlich anders bewertet werden | ||
| STADA ARZNEIMITTEL | - | - | Stada stemmt nächste Übernahme unter neuen Mehrheitsbesitzer | BAD VILBEL (dpa-AFX) - Der hessische Arzneihersteller Stada setzt auch unter neuem Mehrheitseigentümer auf Übernahmen. Der Konzern kauft 16 Marken für Vitamine, Mineralstoffe und Nahrungsergänzungsmittel... ► Artikel lesen | |
| TILRAY BRANDS | 3,915 | -0,89 % | Tilray Brands climbs 8%, extending prior day's gains | ||
| TEVA | 30,400 | 0,00 % | Medincell: UZEDY: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook | Regulatory News:
Medincell (Euronext Paris: MEDCL) partner, Teva Pharmaceuticals (NYSE and TASE: TEVA), announced today that UZEDY U.S. net sales reached a record $77 million in Q2 2026, up 43%... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 413,25 | -0,10 % | Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target | ||
| ABBOTT LABORATORIES | 91,92 | +0,24 % | ABBOTT LABORATORIES - 10-Q, Quarterly Report | ||
| INNOCAN PHARMA | 1,690 | -2,59 % | Innocan Pharma Corporation: Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth | The rapidly growing skincare brand continues to strengthen its position in the U.S. beauty market through innovation, quality, and customer trust.HERZLIYA, Israel and CALGARY, AB, July 29... ► Artikel lesen | |
| MPH HEALTH CARE | 24,600 | +1,23 % | Dividendenbekanntmachungen (10.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD 0,2187 EUR ALPHA BANK SA ADR US02071M5076 0,0187 USD 0,0163 EUR AMERICAN EAGLE OUTFITTERS... ► Artikel lesen |